Cardiovascular Safety of Hydroxychloroquine–Azithromycin in 424 COVID-19 Patients

Background and Objectives: Hydroxychloroquine (HCQ) combined with azithromycin (AZM) has been widely administered to patients with COVID-19 despite scientific controversies. In particular, the potential of prolong cardiac repolarization when using this combination has been discussed. Materials and M...

Descripción completa

Detalles Bibliográficos
Autores principales: Million, Matthieu, Lagier, Jean-Christophe, Hourdain, Jérôme, Franceschi, Frédéric, Deharo, Jean-Claude, Parola, Philippe, Brouqui, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220868/
https://www.ncbi.nlm.nih.gov/pubmed/37241095
http://dx.doi.org/10.3390/medicina59050863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220868/
https://www.ncbi.nlm.nih.gov/pubmed/37241095
http://dx.doi.org/10.3390/medicina59050863

Ejemplares similares